ATE338545T1 - Polymaleinimid-verbindungen und ihre medizinische verwendung - Google Patents

Polymaleinimid-verbindungen und ihre medizinische verwendung

Info

Publication number
ATE338545T1
ATE338545T1 AT02801965T AT02801965T ATE338545T1 AT E338545 T1 ATE338545 T1 AT E338545T1 AT 02801965 T AT02801965 T AT 02801965T AT 02801965 T AT02801965 T AT 02801965T AT E338545 T1 ATE338545 T1 AT E338545T1
Authority
AT
Austria
Prior art keywords
compounds
polymaleinimide
medical uses
relates
maleimide
Prior art date
Application number
AT02801965T
Other languages
English (en)
Inventor
Suren Solanki
William Duncan Potter
Lorraine Anderson
Original Assignee
Ssl Int Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ssl Int Plc filed Critical Ssl Int Plc
Application granted granted Critical
Publication of ATE338545T1 publication Critical patent/ATE338545T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • C07D207/444Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5
    • C07D207/448Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide
    • C07D207/452Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members having two doubly-bound oxygen atoms directly attached in positions 2 and 5 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms, e.g. maleimide with hydrocarbon radicals, substituted by hetero atoms, directly attached to the ring nitrogen atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polyesters Or Polycarbonates (AREA)
AT02801965T 2001-10-25 2002-10-24 Polymaleinimid-verbindungen und ihre medizinische verwendung ATE338545T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0125658.5A GB0125658D0 (en) 2001-10-25 2001-10-25 Medicaments

Publications (1)

Publication Number Publication Date
ATE338545T1 true ATE338545T1 (de) 2006-09-15

Family

ID=9924532

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02801965T ATE338545T1 (de) 2001-10-25 2002-10-24 Polymaleinimid-verbindungen und ihre medizinische verwendung

Country Status (8)

Country Link
US (1) US20050148653A1 (de)
EP (1) EP1438042B1 (de)
AT (1) ATE338545T1 (de)
AU (1) AU2002334233A1 (de)
DE (1) DE60214578T2 (de)
ES (1) ES2269814T3 (de)
GB (1) GB0125658D0 (de)
WO (1) WO2003035058A2 (de)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3129225A (en) * 1961-06-07 1964-04-14 Us Vitamin Pharm Corp Novel 4-oxy-3-maleimidyl betaines
DE1545848A1 (de) * 1965-08-23 1969-10-16 Bayer Ag Verfahren zur Herstellung von Maleinimiden bzw. Isomaleinimiden
US4810638A (en) * 1986-07-24 1989-03-07 Miles Inc. Enzyme-labeled antibody reagent with polyalkyleneglycol linking group
WO1989004318A1 (fr) * 1987-11-11 1989-05-18 Toray Industries, Inc. Complexe de platine et agent therapeutique contre les tumeurs malignes
US4876358A (en) * 1987-11-25 1989-10-24 Texaco Inc. Oxyethylene bismaleimide derivatives
US5380746A (en) * 1989-05-05 1995-01-10 Goedecke Aktiengesellschaft Bis-(1H-indol-3-YL)-maleinimide derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH04120004A (ja) * 1990-09-07 1992-04-21 Ichikawa Gosei Kagaku Kk 防菌防かび剤
JPH05178825A (ja) * 1991-12-26 1993-07-20 Yamanouchi Pharmaceut Co Ltd 新規なペプチド誘導体
US5624949A (en) * 1993-12-07 1997-04-29 Eli Lilly And Company Protein kinase C inhibitors
US5539132A (en) * 1994-01-24 1996-07-23 Johns Hopkins University Cerulenin compounds for fatty acid synthesis inhibition
US6001555A (en) * 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
JP3329161B2 (ja) * 1995-10-31 2002-09-30 松下電器産業株式会社 非水電解液二次電池
JP2863638B2 (ja) * 1996-01-26 1999-03-03 ベーリンガー マンハイム コーポレイション ビスーマレイミド架橋剤

Also Published As

Publication number Publication date
GB0125658D0 (en) 2001-12-19
WO2003035058A2 (en) 2003-05-01
AU2002334233A1 (en) 2003-05-06
EP1438042A2 (de) 2004-07-21
DE60214578D1 (de) 2006-10-19
US20050148653A1 (en) 2005-07-07
WO2003035058A3 (en) 2003-12-31
DE60214578T2 (de) 2007-09-13
ES2269814T3 (es) 2007-04-01
EP1438042B1 (de) 2006-09-06

Similar Documents

Publication Publication Date Title
MXPA04012965A (es) Inhibidores virales.
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
WO1998056761A3 (en) Benzimidazole derivatives
AU2002218167A1 (en) N-phenyl-2-pyrimidine-amine derivatives
WO2002055496A8 (en) Aryl piperidine and piperazine derivatives as inducers of ldl-receptor expression
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
JO2282B1 (en) Oxazole derivatives
EA201000643A1 (ru) Замещенное производное этилендиамина для лечения микобактериальных заболеваний и фармацевтическая композиция на его основе
ATE442142T1 (de) Fredericamycin-derivate als arzneimittel zur tumorbehandlung
EA200500376A1 (ru) Триазольные производные в качестве ингибиторов трансформирующего фактора роста (tgf)
TNSN04203A1 (en) Benzoxazinone-derived compounds, their preparation and use as medicaments
NO20060981L (no) Pyridazinderivater og deres anvendelse som terapeutiske midler
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
MY146279A (en) Compounds affecting glucokinase
DE60315492D1 (de) Medizinisch verwendbare arylethanolamin verbindungen
EA200500377A1 (ru) Пиразольные производные как ингибиторы трансформирующего фактора роста (tgf)
NO20092033L (no) Nye forbindelser
MXPA04005156A (es) Antagonistas del receptor de adenosina a2a.
GB0112348D0 (en) Compounds
MXPA05006889A (es) Compuestos aromaticos como agentes anti-inflamatorios, inmunomoduladores y anti-proliferativos.
SG162614A1 (en) Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors
CA2430967A1 (en) Remedies for bone marrow suppression and infectious diseases and white blood cell count elevating agents
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
UA83832C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и их применение
IL166057A0 (en) Urea-substituted and urethane-substituted acylureas methods for the production thereof and their useas medicaments

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties